XENETIC BIOSCIENCES INC
(NASDAQ: XBIO)

Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.

3.770

-0.210 (-5.28%)
Range 3.770 - -   (-100%)
Open -
Previous Close 3.980
Bid Price 2.940
Bid Volume 10
Ask Price 3.000
Ask Volume 10
Volume 3,412
Value -
Remark
Delayed prices. Updated at 29 Mar 2024 03:26.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis